glp 1 crackdown FDA issued 30 warning letters to telehealth companies for false and misleading claims about compounded GLP-1 products. This marks the second round of enforcement action since the agency's September on misleading FDA on GLP-1 compounders and
Description
Research on this topic is still ongoing, however, and it may take time to determine the long-term effects of these drugs

GLP-1RA drugs came out on top, not only controlling blood glucose but also reducing the risk of major heart-related events and the risk of death overall
class and Im rarely hungry this early in the morning
These adverse reactions are generally mild to moderate and gradually alleviated in most patients (100, 104)
